Thalidomide alone or in combination with fludarbabine are effective treatments for patients with fludarabine-relapsed and refractory CLL
Year: 2005
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: R. R. Furman, J. P. Leonard, S. L. Allen, M. Coleman, T. Rosenthal, J. L. Gabrilove
Language: English
Subfield: Genetics
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2589566794
